ImmunoPrecise Antibodies Ltd. (HYFT) — Free Cash Flow Generation Index

Latest as of October 2020: -0.62x

ImmunoPrecise Antibodies Ltd. (HYFT) has a Free Cash Flow Generation Index of -0.62x as of October 2020. Free cash flow of $-274.98K represents -1% of operating cash flow ($440.23K). See HYFT current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

-0.62x

Free Cash Flow / Operating CF

Free Cash Flow

$-274.98K

USD

Operating Cash Flow

$440.23K

USD

Capital Expenditures

$715.21K

USD

ImmunoPrecise Antibodies Ltd. Free Cash Flow Generation Index (2016–2016)

Historical FCF Generation Index trend for ImmunoPrecise Antibodies Ltd. across 1 annual periods. Explore ImmunoPrecise Antibodies Ltd. cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for ImmunoPrecise Antibodies Ltd. (2016–2016)

Year-by-year Free Cash Flow Generation Index for ImmunoPrecise Antibodies Ltd.. For the full company profile including market capitalisation, see HYFT company net worth.

Year	FCG Index	Free Cash Flow (USD)	Operating CF	Capital Expenditures	YoY Change
2016	0.94x	$266.61K	$284.09K	$17.48K	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).